Stockreport

Glucotrack to File for FDA Exemption Based on 2025 Milestones [Yahoo! Finance]

GlucoTrack, Inc.  (GCTK) 
PDF This submission follows the completion of clinical trials in Brazil and Australia, and is set to be completed during the second quarter of 2026, the company stated. “ [Read more]